Exacerbation of mild lung disorders to lethal pulmonary hypoplasia by a non-coding hypomorphic SNV in a lung-specific enhancer in trans to the frameshifting TBX4 variant

Variants involving TBX4 are associated with a wide variety of disorders, including pulmonary arterial hypertension, ischiocoxopodopatellar syndrome (ICPPS), lethal lung developmental disorders (LLDDs) in neonates, heart defects, and prenatally lethal posterior amelia with pelvic and pulmonary hypoplasia syndrome. The objective of our study was to elucidate the wide variable phenotypic expressivity and incomplete penetrance in a three-generation family with a truncating variant in TBX4 . In addition to exome and genome sequencing analyses, a candidate non-coding regulatory SNV within the lung-specific TBX4 enhancer was functionally tested using an in vitro luciferase reporter assay. A heterozygous frameshift variant c.1115dup (p.Pro373Serfs*14) in TBX4 was identified in patients with mild interstitial lung disease (1), bronchiolitis obliterans (1), recurrent pneumothorax (1), ICPPS (1), LLDD (2), and in unaffected individuals (4). In two deceased neonates with LLDD, we identified a non-coding SNV rs62069651-C located in trans to the mutated TBX4 allele that reduced the TBX4 promoter activity by 63% in the reporter assay. Our findings provide a functional evidence for the recently reported model of complex compound inheritance in which both TBX4 coding and in trans non-coding hypomorphic variants in the lung-specific enhancer of TBX4 contribute to LLDD.